Advertisement

Topics

Mesothelioma Applied Research Foundation Company Profile

14:49 EST 19th November 2017 | BioPortfolio


News Articles [1069 Associated News Articles listed on BioPortfolio]

British Researchers Report Extended Mesothelioma Survival with New Drug, According to Surviving Mesothelioma

Scientists in Surrey and London say two peritoneal mesothelioma patients are still living 10 and 13 years after their diagnosis. (PRWEB) August 03, 2017 Doctors with the Royal Marsden NHS Foundation ...

Scientists at the Foundation for Applied Molecular Evolution Awarded One of Eight Nationwide Transformative Research Awards - Totaling $3 million

Alachua, Florida (PRWEB) October 09, 2017 The National Institutes of Health announced today that one of eight Transformative Researc...

New Study Finds Hope for Mesothelioma Treatment in Measles Virus, According to Surviving Mesothelioma

Minnesota scientists say a particular strain of the measles virus is especially lethal to malignant mesothelioma cells and may form the basis of a new treatment. Raleigh, NC (PRWEB) July 13, 2017 New...

Scientists “Turn Off” Tumor-Protecting Protein in New Mesothelioma Study, According to Surviving Mesothelioma

New research suggests that microRNAs may be the key to downregulating PD-L1 and improving immunotherapy treatment for malignant mesothelioma. Raleigh, NC (PRWEB) June 25, 2017 Australian researchers ...

New Italian Study Highlights Potential of Flavonoid in Mesothelioma Treatment, According to Surviving Mesothelioma

Researchers say compound in chamomile tea increased the survival of mice with human mesothelioma. Raleigh, NC (PRWEB) July 08, 2017 Doctors at the University of Rome say a plant compound found in par...

New Mesothelioma Study Highlights Benefits of Compound in Cruciferous Vegetables, According to Surviving Mesothelioma

Korean researchers say sulforaphane may enhance the cancer-killing power of cisplatin. Raleigh, NC (PRWEB) June 29, 2017 Scientists say the organosulfur compound sulforaphane found in vegetables like...

New Study Shows Advanced Mesothelioma Patients Feel Better After Fluid Drainage Procedure, According to Surviving Mesothelioma

UK doctors say patients with pleural mesothelioma report easier breathing and less pain when their lung fluid buildup is addressed. Raleigh, NC (PRWEB) September 11, 2017 Researchers at Oxford Univer...

New Study Finds Nearly 30 Percent of Mesothelioma Patients Don’t Get Treatment, According to Surviving Mesothelioma

National Cancer Institute researchers say patients over 70 are less likely than younger patients to receive therapy for malignant mesothelioma. Raleigh, NC (PRWEB) August 25, 2017 A new published rep...

PubMed Articles [1758 Associated PubMed Articles listed on BioPortfolio]

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.

- Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose.

The epithelioid, BAP1-negative and p16-positive phenotype predicts prolonged survival in pleural mesothelioma.

Mesothelioma is a relatively uncommon but highly malignant neoplasm. Most patients die of disease within one year of diagnosis, but some have prolonged survival. Prospective identification of these lo...

Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for its Differentiation From Pulmonary Adenocarcinoma.

As there are currently no absolute immunohistochemical positive markers for the definite diagnosis of malignant epithelioid mesothelioma, the identification of additional "positive" markers that may f...

Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033.

Malignant mesothelioma is a malignant tumor on the pleura or the peritoneum caused mostly by asbestos. Although asbestos is not currently used in South Korea, the incidence of mesothelioma is increasi...

Epidemiology of mesothelioma of the pericardium and tunica vaginalis testis.

Malignant mesothelioma most commonly arises in the pleura and peritoneum but also occurs rarely at other anatomical sites with mesothelial tissue, namely, the pericardium and tunica vaginalis testis (...

Clinical Trials [2456 Associated Clinical Trials listed on BioPortfolio]

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

RATIONALE: Studying levels of mesothelin and osteopontin in samples of blood from patients with mesothelioma or atypical mesothelial hyperplasia may help doctors identify biomarkers relate...

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

For patients with malignant pleural mesothelioma that has grown despite treatment with standard chemotherapy, no treatment has yet proven beneficial. The purpose of this study is to find o...

SU5416 in Treating Patients With Malignant Mesothelioma

RATIONALE: SU5416 may stop the growth of malignant mesothelioma by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who ...

A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma

This research study is studying a pair of immunotherapies as a possible treatment for malignant pleural mesothelioma. The drugs involved in this study are: - Durvalumab ...

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Based on results from earlier clinical trials, Pemetrexed may have antitumor activity as a first-line agent in the treatment of mesothelioma. Given this, it is hypothesized that Pemetrexed...

Companies [2770 Associated Companies listed on BioPortfolio]

The Mesothelioma Applied Research Foundation

The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively...

Mesothelioma Applied Research Foundation

Baron & Budd, P.C. .

The national mesothelioma law firm of Baron & Budd, P.C. has a more than 30-year history of “Protecting What’s Right” for asbestos sufferers and their families. As ...

Simmons Firm

The Simmons Firm, headquartered in Alton, Ill., is one of the country’s leading asbestos and mesothelioma litigation firms. With offices in Illinois, Missouri and California,...

Simmons Browder Gianaris Angelides & Barnerd LLC

The Simmons Firm, headquartered in Alton, Ill., is one of the country’s leading asbestos and mesothelioma litigation firms. With offices in Illinois, Missouri and California,...

More Information about "Mesothelioma Applied Research Foundation" on BioPortfolio

We have published hundreds of Mesothelioma Applied Research Foundation news stories on BioPortfolio along with dozens of Mesothelioma Applied Research Foundation Clinical Trials and PubMed Articles about Mesothelioma Applied Research Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mesothelioma Applied Research Foundation Companies in our database. You can also find out about relevant Mesothelioma Applied Research Foundation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record